ArticleScientific reports2024

Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study.

Mimma Rizzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.